News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
719,866 Results
Type
Article (62697)
Company Profile (292)
Press Release (656877)
Multimedia
Podcasts (102)
Webinars (12)
Section
Business (200337)
Career Advice (2955)
Deals (34742)
Drug Delivery (117)
Drug Development (85143)
Employer Resources (163)
FDA (17419)
Job Trends (15258)
News (347517)
Policy (34891)
Tag
Academia (2870)
Academic (2)
Accelerated approval (6)
Adcomms (28)
Allergies (94)
Alliances (52283)
ALS (104)
Alzheimer's disease (1505)
Antibody-drug conjugate (ADC) (149)
Approvals (17380)
Artificial intelligence (300)
Autoimmune disease (29)
Automation (16)
Bankruptcy (349)
Best Places to Work (11942)
BIOSECURE Act (20)
Biosimilars (118)
Biotechnology (209)
Bladder cancer (85)
Brain cancer (32)
Breast cancer (308)
Cancer (2443)
Cardiovascular disease (206)
Career advice (2488)
Career pathing (32)
CAR-T (174)
Cell therapy (491)
Cervical cancer (22)
Clinical research (69020)
Collaboration (920)
Company closure (2)
Compensation (478)
Complete response letters (29)
COVID-19 (2807)
CRISPR (47)
C-suite (259)
Cystic fibrosis (110)
Data (2382)
Decentralized trials (2)
Denatured (34)
Depression (52)
Diabetes (289)
Diagnostics (6588)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (42)
Drug discovery (132)
Drug pricing (125)
Drug shortages (29)
Duchenne muscular dystrophy (104)
Earnings (80349)
Editorial (45)
Employer branding (21)
Employer resources (144)
Events (106569)
Executive appointments (772)
FDA (18851)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (814)
Gene editing (119)
Generative AI (30)
Gene therapy (361)
GLP-1 (821)
Government (4884)
Grass and pollen (6)
Guidances (159)
Healthcare (19662)
Huntington's disease (26)
IgA nephropathy (32)
Immunology and inflammation (153)
Indications (29)
Infectious disease (2972)
Inflammatory bowel disease (159)
Inflation Reduction Act (9)
Influenza (57)
Intellectual property (103)
Interviews (561)
IPO (16117)
IRA (47)
Job creations (3785)
Job search strategy (2050)
Kidney cancer (11)
Labor market (35)
Layoffs (498)
Leadership (24)
Legal (8155)
Liver cancer (81)
Lung cancer (343)
Lymphoma (160)
Machine learning (9)
Management (54)
Manufacturing (336)
MASH (84)
Medical device (13499)
Medtech (13503)
Mergers & acquisitions (19206)
Metabolic disorders (773)
Multiple sclerosis (89)
NASH (22)
Neurodegenerative disease (119)
Neuropsychiatric disorders (30)
Neuroscience (2118)
NextGen: Class of 2025 (7001)
Non-profit (4942)
Now hiring (23)
Obesity (409)
Opinion (269)
Ovarian cancer (80)
Pain (101)
Pancreatic cancer (91)
Parkinson's disease (167)
Partnered (22)
Patents (258)
Patient recruitment (120)
Peanut (49)
People (56768)
Pharmaceutical (73)
Pharmacy benefit managers (19)
Phase I (21255)
Phase II (30171)
Phase III (22871)
Pipeline (1411)
Policy (170)
Postmarket research (2976)
Preclinical (9304)
Press Release (63)
Prostate cancer (114)
Psychedelics (37)
Radiopharmaceuticals (250)
Rare diseases (436)
Real estate (6029)
Recruiting (68)
Regulatory (24171)
Reports (36)
Research institute (2580)
Resumes & cover letters (477)
Rett syndrome (6)
RNA editing (5)
RSV (50)
Schizophrenia (84)
Series A (138)
Series B (94)
Service/supplier (7)
Sickle cell disease (58)
Special edition (19)
Spinal muscular atrophy (162)
Sponsored (30)
Startups (3610)
State (2)
Stomach cancer (14)
Supply chain (68)
Tariffs (51)
The Weekly (66)
Vaccines (802)
Venture capitalists (42)
Weight loss (280)
Women's health (36)
Worklife (19)
Date
Today (192)
Last 7 days (1000)
Last 30 days (3240)
Last 365 days (33359)
2025 (12277)
2024 (35955)
2023 (40437)
2022 (51631)
2021 (56195)
2020 (55139)
2019 (48298)
2018 (36650)
2017 (33916)
2016 (33634)
2015 (38733)
2014 (31998)
2013 (27964)
2012 (29487)
2011 (29679)
2010 (28645)
Location
Africa (1019)
Alabama (56)
Alaska (6)
Arizona (202)
Arkansas (14)
Asia (43068)
Australia (7358)
California (6334)
Canada (2046)
China (560)
Colorado (283)
Connecticut (295)
Delaware (145)
Europe (97880)
Florida (962)
Georgia (212)
Idaho (57)
Illinois (576)
India (27)
Indiana (323)
Iowa (10)
Japan (173)
Kansas (101)
Kentucky (25)
Louisiana (14)
Maine (65)
Maryland (927)
Massachusetts (4823)
Michigan (234)
Minnesota (385)
Mississippi (2)
Missouri (86)
Montana (31)
Nebraska (26)
Nevada (69)
New Hampshire (67)
New Jersey (1823)
New Mexico (27)
New York (1823)
North Carolina (1074)
North Dakota (9)
Northern California (2774)
Ohio (216)
Oklahoma (14)
Oregon (38)
Pennsylvania (1424)
Puerto Rico (14)
Rhode Island (30)
South America (1313)
South Carolina (27)
South Dakota (1)
Southern California (2378)
Tennessee (102)
Texas (951)
United States (24153)
Utah (194)
Virginia (163)
Washington D.C. (65)
Washington State (576)
West Virginia (3)
Wisconsin (54)
719,866 Results for "centers for disease control and prevention cdc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Trump Eyes Steep Cuts to CDC HIV Prevention Program
The CDC budget cuts could pose headwinds for HIV drugmakers like Gilead and Merck but are unlikely to severely cripple their HIV divisions, according to analysts.
March 19, 2025
·
2 min read
·
Tristan Manalac
Vaccines
CDC Vaccine Advisors to Meet in April as Trump Eyes New Agency Director
After withdrawing its nomination for Dave Weldon last week, the Trump administration is now reportedly considering Texas Republican Michael Burgess to head the Centers for Disease Control and Prevention.
March 21, 2025
·
2 min read
·
Tristan Manalac
Regulatory
Senate Democrats Demand Return of Fired CDC Staff:
Reuters
Democratic senators from Georgia, Oregon, Maryland and New Mexico called the Trump administration’s decision to terminate hundreds of CDC staffers reckless and unfair.
March 20, 2025
·
2 min read
·
Tristan Manalac
Government
Trump Picks Vaccine Critic Weldon to Lead CDC, Makary for FDA Head
Career conservative and former congressman Dave Weldon will, if confirmed, act as director of the Centers of Disease Control and Prevention, where his anti-vaccine views will mesh with those of selected Department of Health and Human Services head Robert F. Kennedy Jr.
November 25, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Bavarian Nordic’s Chikungunya Vaccine Receives Recommendation from U.S. CDC’s Advisory Committee on Immunization Practices (ACIP)
April 17, 2025
·
6 min read
Policy
RFK Considers Pulling COVID-19 From CDC’s Vaccine Guidelines for Children:
Politico
Such a change would put the U.S. more in line with guidance in other countries and with the World Health Organization, which recommends one dose for children and adolescents only if they have comorbidities.
April 23, 2025
·
3 min read
·
Tristan Manalac
Podcast
Trump’s Pharma Tariffs, Monarez for CDC, Novo’s New Obesity Play, More
President Donald Trump continues to warn of tariffs on the pharmaceutical industry; Susan Monarez replaces Dave Weldon as CDC director nominee; Novo Nordisk joins the triple-G race; Alnylam wins approval for Amvuttra in ATTR-CM; and Cassava Sciences ends development of simufilam in Alzheimer’s.
March 26, 2025
·
1 min read
·
Heather McKenzie
Bladder cancer
J&J Declares ‘Sustained Disease Control’ With Bladder Cancer Drug-Device Combo
The targeted drug release device TAR-200 shows promising response and disease-free survival rates in specific populations of patients with non-muscle-invasive bladder cancer.
April 28, 2025
·
2 min read
·
Tristan Manalac
Genetown
T2 Biosystems Praises CDC’s Actions Aimed at Optimizing U.S. Hospital Sepsis Programs The U.S. Centers for Disease Control and Prevention Releases 2023 Hospital Sepsis Program Core Elements
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today praised actions taken by the U.S. Centers for Disease Control and Prevention (CDC) aimed at optimizing hospital sepsis programs in the United States.
August 28, 2023
·
6 min read
Vaccines
CDC Reaffirm RSV Vaccination Guidelines, Declines Expanding Coverage to Younger Adults
The CDC’s vaccine advisors on Thursday maintained that respiratory syncytial virus immunization is only recommended for adults aged 75 and older, and in seniors 60 to 74 years who are at risk of severe disease.
October 25, 2024
·
2 min read
·
Tristan Manalac
1 of 71,987
Next
